GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Debt-to-EBITDA

Bluemtec Co (XKRX:439580) Debt-to-EBITDA : 0.00 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bluemtec Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Bluemtec Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Bluemtec Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ₩12,338 Mil. Bluemtec Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Bluemtec Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:439580' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -11.39   Med: -0.87   Max: 23.88
Current: 23.88

During the past 3 years, the highest Debt-to-EBITDA Ratio of Bluemtec Co was 23.88. The lowest was -11.39. And the median was -0.87.

XKRX:439580's Debt-to-EBITDA is ranked worse than
96.5% of 428 companies
in the Healthcare Providers & Services industry
Industry Median: 2.565 vs XKRX:439580: 23.88

Bluemtec Co Debt-to-EBITDA Historical Data

The historical data trend for Bluemtec Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Debt-to-EBITDA Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
Debt-to-EBITDA
-11.39 -0.50 -0.87

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial -0.20 175.74 41.18 -3.77 -

Competitive Comparison of Bluemtec Co's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Bluemtec Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bluemtec Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's Debt-to-EBITDA falls into.



Bluemtec Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Bluemtec Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4283.717 + 6671.8) / -12660.349
=-0.87

Bluemtec Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 12337.84
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Bluemtec Co  (XKRX:439580) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Bluemtec Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bluemtec Co (XKRX:439580) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines